Beyond, INC

Bed Bath & Beyond, Inc. has officially changed its corporate name to Neighborhood Intelligence, Inc. and is transferring its stock and warrants listing from the NYSE to the Nasdaq.

Bed Bath & Beyond, Inc. announces the appointment of Jill Windrum as Chief Accounting Officer and Deputy Chief Financial Officer, effective August 31, 2026.

Bed Bath & Beyond, Inc. files an amendment to its Form 8-K to include financial statements and pro forma information related to its acquisition of The Container Store Holdings, LLC and The Brand House Collective, Inc.

Bed Bath & Beyond, Inc. announced its entry into a definitive Agreement and Plan of Merger with F9 Brands, Inc., a transaction valued at $7 million in cash plus stock and other considerations.

Bed Bath & Beyond, Inc. has entered into an indenture for $112,553,000 in 5.00% Convertible Senior Notes due 2033, following its acquisition of The Container Store Holdings, LLC.

Bed Bath & Beyond, Inc. has completed the acquisition of TwoPonds, Inc. by merging it with its subsidiary, SFV Merger Sub, Inc., issuing 7,200,000 shares of common stock as consideration.

Bed Bath & Beyond, Inc. filed its Q2 2026 Form 10-Q, reporting increased net revenue driven by acquisitions, but also significant net losses and rising operating expenses.

Bed Bath & Beyond, Inc. reported a significantly reduced net loss and improved operating cash flow for Q3 2025, driven by efficiency gains and strategic brand management, despite a revenue decline.

Beyond, Inc. reported a substantial decrease in net revenue for the second quarter and first half of 2025, driven by lower order volumes, though the company achieved improved gross margins and reduced net losses through aggressive cost management and strategic asset sales.

Beyond, Inc.'s Q1 2025 revenue decreased by 39.4% year-over-year, driven by a decline in orders, though gross margin improved due to merchandising actions and reduced carrier costs.

Beyond Inc. experienced a decrease in revenue and gross profit in the third quarter of 2024, primarily due to a reduction in orders delivered, partially offset by an increase in average order value.

Beyond Inc. experienced a 5.7% decrease in net revenue for the second quarter of 2024, primarily due to a decline in average order value.

Bed Bath & Beyond, Inc. reports a 25% revenue decrease in 2025, alongside improved gross margins and ongoing strategic transformations including a pending merger with The Brand House Collective.

Beyond, Inc.'s 10-K filing reveals a year of strategic shifts, financial losses, and evolving business models amidst a competitive e-commerce environment.

Beyond, Inc. has filed an amendment to its annual report to include financial statements for tZERO Group, Inc., a significant subsidiary, while also noting tZERO's ongoing concerns about its ability to continue as a going concern.

Beyond, Inc. has filed an amendment to its 2023 annual report to replace previously filed auditor consents and include updated certifications from its principal executive and financial officers.

Beyond Inc.'s 10-K filing reveals a year of strategic changes, including a name change, brand acquisition, and financial performance impacted by economic headwinds and investments.

Marcus Lemonis, EXECUTIVE CHAIRMAN & CEO and a Director of Beyond, Inc., purchased 23,094 shares of common stock on August 12, 2026 for $4.30 per share.

Brian Larose, Chief Financial Officer of Beyond, Inc., received 388,889 shares of common stock on August 6, 2026.

Marcus Lemonis, EXECUTIVE CHAIRMAN & CEO and a Director of Beyond, Inc., purchased 43,382 shares of common stock on August 5, 2026 for $4.67 per share.

Bed Bath & Beyond, Inc. has entered into a definitive merger agreement to acquire Fathom Holdings Inc. in an all-stock transaction.

Bed Bath & Beyond announced an agreement to acquire Fathom Holdings Inc., aiming to create the nation's first end-to-end homeownership platform.

Joanna M. Burkey, a Director at Bed Bath & Beyond, Inc., reported the sale of 9,943 shares of common stock for approximately $6.38 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Bed Bath & Beyond, Inc. is seeking stockholder approval for a significant increase in authorized common stock and a new equity incentive plan, alongside the election of directors and ratification of auditors at its upcoming 2026 Annual Meeting.

Beyond, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

Beyond Inc. is soliciting proxies for its 2025 Annual Meeting of Stockholders, featuring votes on director elections, auditor ratification, executive compensation, and amendments to the equity incentive plan.

Beyond, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.

Beyond Inc.'s proxy statement outlines proposals for the upcoming annual meeting, including board declassification, executive compensation adjustments, and equity plan amendments.

Bed Bath & Beyond, Inc. provides Brand House Collective, Inc. with $20 million in new delayed-draw term loan commitments, increasing its beneficial ownership to 49.8%.

Kirkland's, Inc. has amended its existing credit agreement with Beyond, Inc., securing an additional $5.2 million in debt financing, while granting Beyond, Inc. significant governance rights and facing a 'going concern' qualification in its latest audited financial statements.

Beyond, Inc. has significantly increased its beneficial ownership in Kirkland's, Inc. to 40% of outstanding common stock, following shareholder approval of share issuances related to a subscription agreement and convertible note conversion.

Morgan Stanley has reported a decrease in its beneficial ownership of Bed Bath & Beyond, Inc. common stock to 5.4%.

Mitchell and Sharon Rosen, along with their associated trusts, have disclosed a combined beneficial ownership of 7,200,000 shares, representing 8.9% of Bed Bath & Beyond's common stock.

A joint filing reveals Mitchell A. Rosen, Sharon Rosen, and associated trusts now collectively hold 8.9% of Bed Bath & Beyond's common stock.

Amplify Investments and Amplify ETF Trust have jointly reported beneficial ownership of 9.4% of Bed Bath & Beyond's common stock as of June 30, 2026.

Amplify Investments LLC and Amplify ETF Trust have jointly filed a Schedule 13G, reporting beneficial ownership of 10.7% of Bed Bath & Beyond's common stock as of May 31, 2026.

Amplify Investments LLC and Amplify ETF Trust have jointly filed a Schedule 13G, reporting beneficial ownership of 8.7% of Bed Bath & Beyond, Inc. common stock as of March 31, 2026.